Learn More
Antiplatelet drugs are a cornerstone of tretment in patients with acute coronary syndromes leading to significant reduction of recurrent ischemic events [1]. Benefits of antiplatelet therapy may be(More)
BACKGROUND The results of clinical trials assessing the effect of late opening of infarct-related artery (IRA) on left ventricular ejection fraction (LVEF) and size in stable patients are equivocal,(More)
BACKGROUND Microvascular obstruction (MVO) is a cardiac magnetic resonance (CMR) marker of no-reflow in ST-segment elevation myocardial infarction (STEMI). It remains unresolved whether the infarct(More)